The pandemic exposed the warts in a medical device manufacturing supply chain. Those companies with well-established relationships fared better than those without them. Ease of communication seemed to be paramount, while supply chain geography was a point of focus for many as well. This panel will discuss the vision for the new supply chain make-up and the implications for those involved, from OEM to service provider.